No obvious pathological changes were observed in the different tissues. == Cellular uptake in vitro == The cellular uptakes of FMNPs and RGD-FMNPs were verified through fluorescent microscopy, TEM, and Prussian blue staining (Figures five, 6). breast cancer using MRI and OI. The synthesized RGD-FMNPs could be potentially used for biomedical imaging in the future. Keywords: Fluorescent magnetic nanoparticles (FMNPs), magnetic resonance imaging (MRI), optical imaging (OI), ruthenium complexes, RGD, breast cancer == Introduction == Breast cancer is the most common cancer of women except for skin cancer, and it has become the second leading cause of cancer deaths in women cancers [1]. The most effective way to lessen breast cancer mortality and morbidity is early detection and diagnosis. Thus, it is important to develop a noninvasive imaging method for the early diagnosis of breast cancer. Owing to the unique magnetic features and important applications in biomedicine and therapeutics, magnetic nanoparticles (MNPs) possess attracted much attention Manitimus during the past few decades. Among the various magnetic materials, superparamagnetic iron oxides (SPIOs) have been considered as best candidates to get biological applications due to their superparamagnetism, high saturation magnetization and rapid magnetic response to the external magnetic field. For example , SPIOs have been widely used because contrast providers for noninvasive magnetic resonance imaging (MRI). In order to enhance the sensitivity of MRI, great efforts have been made to boost the relaxivity of SPIOs by increasing the particle size [2]. However , there is a superparamagnetic to ferromagnetic transition with increasing particle sizes. Thus, the large ferromagnetic particles easily aggregate in physiological environments [3, 4]. Recently, it is found that magnetic nanoclusters (MNCs) composed of multiple small MNPs can retain the superparamagnetic characters and simultaneously, the transverse relaxivity increases noticeably with the increasing sizes of MNCs [5-11]. This phenomenon provides great potential of MNCs for their applications in MRI. Besides the magnetic properties, the biocompatibility of magnetic components is very important to get clinical applications. Although iron is an element of the human body, the high local concentration of iron cations caused by degradation of SPIOs is still toxic to organisms. On the other hand, the aggregation of MNCs in physiological environments is also a big problem that limits their application in the biomedical field. Surface Manitimus coating can not only prevent iron leaching in biological environments, but also improves the dispersibility of MNCs in solution. Silica has been used as a perfect material to coat various metal oxides because of its superb biocompatibility and abundant Si-OH active provides. However , the silica shell in these works is generally used as a protecting layer; especially, the silica coating on MNCs with Manitimus fluorescent properties are rarely reported. The ruthenium (II) complexes can be doped into the silica coating to form a fluorescent shell for optical imaging. Thence the fluorescent silica coating can combine with the Rabbit Polyclonal to OR2T2 magnetic properties of MNCs, which are termed fluorescent magnetic Manitimus nanoparticles (FMNPs), to permit both OI and MRI. The ruthenium (II) complexes would be doped into the silica shell as a constituent part of the fluorescent shell to avoid quenching due to the assimilation of fluorescent molecules [12-14]. Definitely, magnetic fluorescent particles cannot only be used for MRI but also for optical imaging, thus providing great guarantee for tumor detection. Focusing on is another issue needs to be regarded as for imaging. To achieve this aim, various biological molecules such as proteins, antibodies, peptides, and oligo-nucleotides have been demonstrated because targeting molecules. As an essential finding, RGD peptide (arginine-glycine-aspartic acid) can selectively combine with the integrin v3which is over expressed in several types of malignancies such as breast cancer,.